Your Doctor Said "Lose Weight."
Your Liver Said "I'm Dying."
80-100 million Americans have fatty liver disease. The only FDA-approved drug costs $47,400 a year. For everyone else, the medical advice is "lose weight and come back in 6 months." Amla addresses the liver inflammation and oxidative damage your doctor can't prescribe for.
Try Loomi Amla →
80 Million Americans Have Fatty Liver.
Almost None Have a Treatment Plan.
NAFLD/MASLD affects up to 30% of the global population. The only FDA-approved drug costs $47,400/year, works in only ~25% of patients, and is limited to advanced fibrosis. For the other 99%? "Lose weight and come back in 6 months."
"Just Lose Weight"
That's the standard medical advice for fatty liver. No prescription. No supplement recommendation. No protocol. Just a directive that 80% of patients fail to maintain long-term — while their liver enzymes keep climbing and the fat accumulation progresses toward inflammation, fibrosis, and eventually cirrhosis.
Rezdiffra: $47,400/Year
The only FDA-approved drug for fatty liver (MASH with Stage 2-3 fibrosis). It works in about 25% of patients. Side effects include nausea and diarrhea. And it's not approved for early-stage fatty liver — only advanced fibrosis. For the 80+ million Americans with NAFLD who haven't progressed to advanced fibrosis, there is no approved pharmaceutical treatment. Period.
Your Liver Is Inflaming Silently
NAFLD has no symptoms in early stages. You feel fine while fat accumulates in liver cells, triggers oxidative stress, and initiates chronic inflammation. By the time your ALT and AST elevate — the first lab signal — the inflammatory damage cycle is already running. 10-30% of NAFLD cases progress to NASH/MASH. 15-25% of those progress to advanced fibrosis. 20% of those reach cirrhosis.
"Lean NAFLD" — It's Not Just Overweight
Up to 25% of people with fatty liver are NOT overweight. Normal BMI. Healthy-looking. But the liver is still accumulating fat, still inflaming, still progressing. "Lose weight" doesn't apply when you're already lean. These patients have the LEAST treatment options and the MOST frustration — they can't even follow the only advice they're given.
Stop the Inflammation. Protect the Cells.
Reverse the Fat Accumulation.
Published research shows amla PREVENTED fatty liver development and REVERSED existing steatosis and fibrosis — through mechanisms no lifestyle change alone can replicate.
Cascading Antioxidants Halt Liver Oxidative Damage
Fatty liver disease is driven by a vicious cycle: fat accumulates in liver cells → generates free radicals → oxidative stress damages the cells → triggers inflammatory response → inflammation causes MORE fat accumulation and cell death. Amla's emblicanins break this cycle at the oxidative stress step. They're cascading antioxidants — Emblicanin-A transforms into Emblicanin-B during radical scavenging, providing sustained antioxidant protection at the liver cell level. Published research shows amla is "effective in preventing/ameliorating the toxic effects" of multiple hepatotoxic agents on the liver.
FXR & LXR Activation — Liver Fat Metabolism Restored
In a published study, amla increased the expression of two critical liver proteins: Farnesoid X Receptor (FXR) and Liver X Receptor (LXR). These receptors are the master regulators of lipid metabolism in the liver — they control how fat is processed, stored, and cleared. When amla activated these receptors, fatty liver was PREVENTED even in a high-fructose diet model designed to cause it. The liver's own fat-clearing machinery was restored.
AMPK Activation — Liver Cell Energy for Repair
Fat-overwhelmed liver cells have damaged mitochondria — the power plants that generate cellular energy. Without mitochondrial power, liver cells can't process fat, can't repair damage, can't recover. They just accumulate more fat and become more inflamed. Amla activates AMPK — the master switch for mitochondrial biogenesis — generating NEW mitochondria inside liver cells. New power supply. The liver cells can finally process the fat that's been accumulating and repair the damage that's been building.

One Compound. Three Liver Actions.
Protect. Restore. Clear.
Amla doesn't just reduce liver enzymes — it addresses the oxidative stress, restores the fat-metabolism machinery, and rebuilds the mitochondrial energy your liver cells need to clear the fat that's accumulated.
Standardized Amla Extract (60% Emblicanins)
Published hepatoprotective research spanning decades. Amla has been shown to protect against liver damage from ethanol, paracetamol, heavy metals, and metabolic stress. Its emblicanins are cascading antioxidants — one molecule cascades through multiple rounds of free radical neutralization — providing sustained protection at the liver cell level. In NAFLD research, amla extract decreased ALT, AST, LDL, and triglycerides while attenuating both hepatic steatosis (fat accumulation) AND fibrosis (scarring).
FXR & LXR Activation — Liver Fat Metabolism
Fat accumulates in the liver when the lipid metabolism machinery breaks down. Amla activates Farnesoid X Receptor (FXR) and Liver X Receptor (LXR) — the master regulators that control how your liver processes, stores, and clears fat. In a published study, amla PREVENTED fatty liver entirely in a high-fructose model by restoring these receptor pathways. Your liver's own fat-clearing system comes back online.
AMPK Activation — Energy for Liver Cell Recovery
Fat-overwhelmed liver cells have failing mitochondria. Without cellular energy, they can't process fat, can't repair damage, can't recover. They just accumulate more and inflame further. Amla activates AMPK — generating NEW mitochondria inside liver cells. New power supply. The liver cells finally have the energy to clear accumulated fat and reverse the damage. Glutathione — the liver's master detox antioxidant — increased 53.2% in the clinical trial.
The First 12 Weeks
Fatty liver develops over years. It won't reverse in days. But liver enzymes respond to intervention within weeks — your next blood panel tells the story.
Inflammation Begins Declining
Amla's anti-inflammatory and antioxidant effects are among the fastest to manifest. The chronic inflammation driving liver damage starts cooling. Most people notice improved energy and reduced bloating — signs that the liver's workload is lightening. Glutathione production ramps up, supporting the liver's own detoxification capacity.
Liver Enzymes Start Moving
ALT and AST — the markers of liver cell damage — typically begin trending downward during this window. If you get bloodwork at week 6, you'll likely see early movement. Some customers report the "heavy" feeling in their upper right abdomen reducing. Digestion often improves as liver function recovers.
Metabolic Markers Improve
LDL, triglycerides, and fasting glucose begin normalizing as liver fat metabolism is restored through FXR/LXR activation. The clinical trial showed LDL -21.8%, triglycerides -19.2%, and HDL +22.2% — these changes reflect the liver PROCESSING fat properly again, not just reducing it through calorie restriction.
Lab Panel Validation
This is when your comprehensive metabolic panel becomes the most meaningful data point. Bring your pre-amla labs and your 12-week labs to your doctor. The numbers tell the story. Many customers report their GI specialist commenting on the improvement before they even mention the supplement. Continued daily use supports ongoing liver protection and fat metabolism.
Real People. Real Liver Recovery.
"ALT was 78. AST was 56. My GI doctor said 'lose 20 pounds and come back in 6 months.' That was the whole plan. No medication. No supplement recommendation. No urgency — just a shrug and a directive I'd been failing at for 3 years. Started amla because the hepatoprotective data was compelling. Four months later: ALT 34. AST 29. Both in normal range. I did lose 8 pounds — but my doctor said the enzyme improvement exceeded what 8 pounds could explain. Something else was working."
"'Lean NAFLD.' I'm 5'6, 135 pounds. My doctor couldn't believe the ultrasound — moderate fatty liver in someone who exercises 4x/week and eats clean. His only advice: 'reduce sugar and saturated fat.' I was already doing both. I felt abandoned. Started amla because it addresses the liver DIRECTLY — not through weight loss, which wasn't my issue. Three months: ALT dropped from 62 to 38. Ultrasound shows 'mild improvement in echogenicity.' First real evidence that something is changing."
"Type 2 diabetic. Fatty liver for 6 years. My A1C is managed at 6.8 but my liver kept getting worse. ALT was 91 at its highest. My endocrinologist and my GI doctor were both watching it but neither could prescribe anything — Rezdiffra wasn't right for my stage. Five months on amla: ALT is 42. Triglycerides dropped from 234 to 161. My energy is better than it's been in years. My GI doctor said 'keep doing what you're doing.' I plan to."
"Honest review at 7 weeks. I haven't had bloodwork yet — that's scheduled for week 12. What I CAN say: the bloating after meals has reduced noticeably. The dull heaviness I used to feel under my right ribs after eating is much less frequent. My energy in the afternoon is better. These are subjective but they're consistent changes I hadn't experienced from milk thistle, NAC, or any other liver supplement I've tried. Four stars until I see the numbers."
Everything You Need to Know
Milk thistle (silymarin) is a hepatoprotective antioxidant with modest evidence for liver enzyme improvement. But it doesn't activate the FXR/LXR receptors that control liver fat metabolism, and it doesn't trigger AMPK-driven mitochondrial biogenesis. Amla provides cascading antioxidant protection (like milk thistle but sustained), PLUS restores the liver's fat-clearing machinery, PLUS rebuilds cellular energy for repair. It's milk thistle's job plus two additional layers most liver supplements don't have.
Yes — and lean NAFLD patients are arguably the most underserved. "Lose weight" doesn't apply when you're already at a healthy BMI. Amla addresses the liver directly through oxidative stress reduction, fat metabolism restoration (FXR/LXR activation), and mitochondrial recovery (AMPK). These mechanisms work regardless of body weight because they target the liver cells themselves, not the caloric balance.
In published research, amla extract decreased ALT and AST levels alongside reducing hepatic steatosis and fibrosis. Many of our customers report meaningful ALT/AST improvement within 8-12 weeks. However, liver enzymes are influenced by multiple factors — diet, alcohol, other medications, exercise, and the severity of existing liver damage all play a role. We recommend getting baseline labs before starting and follow-up labs at 12 weeks to track your individual response.
Many NAFLD patients are also Type 2 diabetic and take metformin. In published clinical trials, amla was studied alongside existing metabolic therapies without reported adverse interactions. Both metformin and amla activate AMPK — through different mechanisms — so they're mechanistically complementary rather than conflicting. Always inform your doctor and pharmacist about any supplement you're adding to your medication regimen.
The "wait and come back" approach is the standard of care — because until recently there was nothing to prescribe. But "wait" means the liver continues accumulating fat and inflaming while you wait. Starting amla now means your liver has daily antioxidant protection and fat-metabolism support during that waiting period. By your next ultrasound, you're not just checking — you're comparing against a baseline where you were actively supporting liver health.
NAC (N-acetyl cysteine) is a glutathione precursor — it helps the liver produce its master detoxification antioxidant. It's a solid supplement for liver support. But NAC provides the raw material for glutathione production — it doesn't address fat metabolism (FXR/LXR), doesn't generate new mitochondria (AMPK), and doesn't provide the sustained cascading antioxidant protection that amla does. They're complementary: NAC supplies glutathione precursors, amla provides the broader hepatoprotective and metabolic-restoration framework.
Most customers report ALT/AST improvement at their 10-12 week labs. Some see movement as early as 6 weeks. Triglycerides and LDL may shift in the 8-12 week window. We recommend baseline bloodwork before starting and follow-up at 12 weeks. Bring both results to your doctor — the trend between the two panels is the most meaningful data point. The 90-day guarantee aligns with this timeline.
90 days. No questions asked. Liver recovery takes time and is best evaluated through bloodwork, not subjective feeling. Take it for 90 days, get your labs, and if your enzymes and metabolic markers haven't improved, email us for a full refund. The guarantee is designed around the lab timeline — because the numbers are what matter.
Your Doctor Said "Lose Weight."
Your Liver Needs More Than That.
80 million Americans have fatty liver. The medical plan for most of them is "come back in 6 months." Amla addresses the liver directly — reducing inflammation, restoring fat metabolism, and rebuilding the cellular energy your liver needs to heal.
Try Loomi Amla →Important: Loomi Amla is a dietary supplement intended to support healthy liver function and lipid metabolism. This product does not treat, cure, or prevent non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic steatohepatitis (NASH/MASH), fibrosis, or cirrhosis. It is not a replacement for Rezdiffra or any prescribed medication. If your liver enzymes are elevated, continue monitoring with your healthcare provider. Fatty liver disease can progress silently — regular medical evaluation is essential.
*Hepatoprotective data cited includes published preclinical studies (FXR/LXR activation preventing fatty liver, steatosis/fibrosis reduction in NAFLD models) and a published human randomized, double-blind, placebo-controlled clinical trial (hsCRP, lipid, and glutathione results). Individual results vary. Testimonials represent individual experiences and are not guaranteed outcomes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Loomi Nutrition. All rights reserved.